Corrigendum to "Magnetic Resonance Imaging and targeted biopsies compared to transperineal mapping biopsies prior to salvage focal therapy/ablation in localised and metastatic recurrent prostate cancer after radiotherapy. Primary Outcomes from the FORECAST Trial" [Eur Urol 2022;81(6):598-605]

Eur Urol. 2023 Apr;83(4):e117-e118. doi: 10.1016/j.eururo.2023.01.004. Epub 2023 Jan 19.
No abstract available

Publication types

  • Published Erratum